SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-17-067407
Filing Date
2017-11-09
Accepted
2017-11-09 16:29:11
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 a17-26160_1424b5.htm 424B5 325979
2 GRAPHIC g261601bui001.jpg GRAPHIC 1811
3 GRAPHIC g261601bui002.jpg GRAPHIC 6165
4 GRAPHIC g261601bai001.jpg GRAPHIC 1794
5 GRAPHIC g261601bai002.jpg GRAPHIC 3282
6 GRAPHIC g261601bmi001.jpg GRAPHIC 2305
  Complete submission text file 0001104659-17-067407.txt   349058
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214882 | Film No.: 171191271
SIC: 2835 In Vitro & In Vivo Diagnostic Substances